for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Sanofi India Ltd

SANO.NS

Latest Trade

6,945.10INR

Change

-6.25(-0.09%)

Volume

666

Today's Range

6,862.25

 - 

6,976.70

52 Week Range

5,280.00

 - 

7,000.00

As of on the National Stock Exchange of India ∙ Minimum 15 minute delay

Latest Developments

Sanofi India Sept-Quarter Profit Rises

Nov 12 (Reuters) - Sanofi India Ltd <SANO.NS>::SEPT-QUARTER PROFIT 1.27 BILLION RUPEES VERSUS 1.19 BILLION RUPEES YEAR AGO.SEPT-QUARTER REVENUE FROM OPERATIONS 7.79 BILLION RUPEES VERSUS 7.44 BILLION RUPEES YEAR AGO.

Sanofi India June-Quarter Profit Falls

July 29 (Reuters) - Sanofi India Ltd <SANO.NS>::JUNE-QUARTER PROFIT 974 MILLION RUPEES VERSUS 996 MILLION RUPEES YEAR AGO.JUNE-QUARTER REVENUE FROM OPERATIONS 7.48 BILLION RUPEES VERSUS 6.83 BILLION RUPEES YEAR AGO.

Indian Pharma Firms Sent Notices By Govt Body For Introducing Drugs Without Approval

July 23 (Reuters) - :INDIAN COS INTRODUCING 22 DRUGS WITHOUT PRIOR APPROVAL OF THE NATIONAL PHARMACEUTICAL PRICING AUTHORITY HAVE BEEN ISSUED NOTICES - GOVERNMENT STATEMENT.NPPA HAS SO FAR ISSUED DEMAND NOTICES FOR AN AMOUNT OF 1.01 BILLION RUPEES AGAINST DEFAULTING COMPANIES - GOVERNMENT STATEMENT.INDIAN COMPANIES ISSUED NOTICES BY NPPA INCLUDE ALEMBIC PHARMA, BIOCON LTD, CIPLA, LUPIN, WOCKHARDT, SANOFI INDIA, DR REDDYS LABS - GOVERNMENT.

Sanofi India Dec-Qtr Profit Rises

Feb 26 (Reuters) - Sanofi India Ltd <SANO.NS>::DEC QUARTER PROFIT 793 MILLION RUPEES VERSUS 760 MILLION RUPEES YEAR AGO.DEC QUARTER GROSS SALES 6.77 BILLION RUPEES VERSUS 6.32 BILLION RUPEES YEAR AGO.

Sanofi India Recalls One Batch Of Lasix® As Directed By Kerala Drug Control Department

Nov 13 (Reuters) - Sanofi India Ltd <SANO.NS>::SAYS HAVE RECALLED STOCKS OF ONE BATCH OF LASIX® FROM MARKET BASED ON DIRECTIVE ISSUED BY KERALA DRUG CONTROL DEPARTMENT.SAYS RECALL WILL NOT HAVE ANY MATERIAL IMPACT ON FINANCIAL STATEMENTS.SAYS CONTROL SAMPLES ARE IN LINE WITH DEFINED QUALITY PARAMETERS AND DO NOT SHOW ANY DEVIATION.

Sanofi India Sept-Qtr Profit Rises

Oct 31 (Reuters) - Sanofi India Ltd <SANO.NS>::SEPT QUARTER NET PROFIT 1.19 BILLION RUPEES VERSUS 1.16 BILLION RUPEES YEAR AGO.SEPT QUARTER REVENUE FROM OPERATIONS 7.44 BILLION RUPEES VERSUS 6.68 BILLION RUPEES YEAR AGO.

India's Sanofi India June-Qtr Profit Rises

July 25 (Reuters) - Sanofi India Ltd <SANO.NS>::JUNE QUARTER PROFIT 996 MILLION RUPEES VERSUS 737 MILLION RUPEES YEAR AGO.JUNE QUARTER TOTAL REVENUE FROM OPERATIONS 6.84 BILLION RUPEES VERSUS 6.01 BILLION RUPEES YEAR AGO.

Sanofi India Approves Appointment Of Charles Billard As CFO

July 25 (Reuters) - Sanofi India Ltd <SANO.NS>::SAYS APPROVED APPOINTMENT OF CHARLES BILLARD AS CFO.DECLARED INTERIM DIVIDEND OF 18 RUPEES PER SHARE.

Sanofi India Gets Shareholders' Nod For Appointment Of Rajaram Narayanan As MD

May 9 (Reuters) - Sanofi India Ltd <SANO.NS>::GETS SHAREHOLDERS' NOD FOR APPOINTMENT OF RAJARAM NARAYANAN AS MD.

Sanofi India Appoints Charles Billard As CFO

May 8 (Reuters) - Sanofi India Ltd <SANO.NS>::SAYS CO APPROVED APPOINTMENT OF CHARLES BILLARD AS CFO.SANOFI INDIA LTD <<<SANO.NS>>> SAYS LIONEL GUERIN, CURRENT CFO, WILL TAKE UP NEW ROLE WITHIN SANOFI GROUP AND WILL STEP DOWN AS CFO.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up